BRAIN TECH STARTUP SCIENCE CORP. RAISES $230 MILLION TO TREAT BLINDNESS

Summary from the TLDR newsletter

Neurotechnology company Science Corp. has raised $230 million, bringing its valuation to $1.5 billion. The funds will be used to commercialize its implant for blindness and develop even more advanced brain devices. Science Corp. is now the second-most valuable brain implant company after Neuralink. Its retina implant, PRIMA, is a chip that sits at the back of the eye to help blind people see with the assistance of a special pair of glasses that projects images into the eye. It has been demonstrated to improve vision for patients with advanced age-related macular degeneration. The device is currently under regulatory review in Europe and the US.